These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT, Gentile P, Tarectecan A, Fuchs A. Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [Abstract] [Full Text] [Related]
5. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M. Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [Abstract] [Full Text] [Related]
6. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Bassarova AV, Nesland JM, Davidson B. Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331 [Abstract] [Full Text] [Related]
7. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis. Onofre FB, Onofre AS, Pomjanski N, Buckstegge B, Grote HJ, Böcking A. Cancer; 2008 Jun 25; 114(3):204-15. PubMed ID: 18306350 [Abstract] [Full Text] [Related]
8. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. Klech H, Rona G, Hutter C, Bayer PM, Kummer F. Wien Klin Wochenschr; 1986 Sep 12; 98(17):564-73. PubMed ID: 3020811 [Abstract] [Full Text] [Related]
9. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR, Zhai J. Diagn Cytopathol; 2005 Mar 12; 32(3):137-44. PubMed ID: 15690333 [Abstract] [Full Text] [Related]
10. Immunohistochemical study of lysozyme, alpha 1-anti-chymotrypsin, tissue polypeptide antigen, keratin and carcinoembryonic antigen in effusion sediments. Permanetter W, Wiesinger H. Acta Cytol; 1987 Mar 12; 31(2):104-12. PubMed ID: 2435101 [Abstract] [Full Text] [Related]
11. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion. Dejmek A, Hjerpe A. Diagn Cytopathol; 2005 Mar 12; 32(3):160-6. PubMed ID: 15690331 [Abstract] [Full Text] [Related]
12. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry. Tickman RJ, Cohen C, Varma VA, Fekete PS, DeRose PB. Acta Cytol; 1990 Mar 12; 34(4):491-6. PubMed ID: 2197840 [Abstract] [Full Text] [Related]
13. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions. Sehested M, Ralfkjaer E, Rasmussen J. Acta Cytol; 1983 Mar 12; 27(2):124-7. PubMed ID: 6340401 [Abstract] [Full Text] [Related]
14. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Ordóñez NG. Am J Surg Pathol; 1989 Apr 12; 13(4):276-91. PubMed ID: 2648877 [Abstract] [Full Text] [Related]
15. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Rakha EA, Patil S, Abdulla K, Abdulkader M, Chaudry Z, Soomro IN. Diagn Cytopathol; 2010 Dec 12; 38(12):874-9. PubMed ID: 20049969 [Abstract] [Full Text] [Related]
16. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Miédougé M, Rouzaud P, Salama G, Pujazon MC, Vincent C, Mauduyt MA, Reyre J, Carles P, Serre G. Br J Cancer; 1999 Nov 12; 81(6):1059-65. PubMed ID: 10576665 [Abstract] [Full Text] [Related]
17. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Shield PW, Koivurinne K. Cytopathology; 2008 Aug 12; 19(4):218-23. PubMed ID: 17916095 [Abstract] [Full Text] [Related]
18. New approaches in the diagnostic procedure of malignant pleural effusions. Terracciano D, Di Carlo A, Papa P, Cicalese M, Maietta P, Cecere C, Mariano A, Macchia V. Oncol Rep; 2004 Jul 12; 12(1):79-83. PubMed ID: 15201963 [Abstract] [Full Text] [Related]
19. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Su XY, Li GD, Liu HB, Jiang LL. Ai Zheng; 2004 Oct 12; 23(10):1185-9. PubMed ID: 15473932 [Abstract] [Full Text] [Related]
20. [GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions]. Daste G, Gioanni J, Lauque D, Kremps M, Mazeau C, Paquis P, Schneider M. Arch Anat Cytol Pathol; 1997 Oct 12; 45(4):185-91. PubMed ID: 9406475 [Abstract] [Full Text] [Related] Page: [Next] [New Search]